Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.78 | 7.29658792651 | 38.1 | 41.6 | 36.105 | 134911 | 40.34812258 | CS |
| 4 | 10.92 | 36.4485981308 | 29.96 | 41.6 | 29.68 | 106393 | 36.13410793 | CS |
| 12 | 24.48 | 149.268292683 | 16.4 | 41.6 | 15.82 | 97248 | 28.50896747 | CS |
| 26 | 23.98 | 141.893491124 | 16.9 | 41.6 | 15.0001 | 73337 | 26.72163068 | CS |
| 52 | 23.98 | 141.893491124 | 16.9 | 41.6 | 15.0001 | 73337 | 26.72163068 | CS |
| 156 | 23.98 | 141.893491124 | 16.9 | 41.6 | 15.0001 | 73337 | 26.72163068 | CS |
| 260 | 23.98 | 141.893491124 | 16.9 | 41.6 | 15.0001 | 73337 | 26.72163068 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
